Buying a Pharmacy in the UK: Financial & Tax Due Diligence Checklist for 2026

Buying a pharmacy can give you an established patient base, existing prescription activity, trained staff and operating infrastructure from day one. But an established pharmacy can also come with liabilities, weak margins, poor financial controls, overstated earnings or regulatory issues that are difficult to see from the headline asking price.

That is why buying a pharmacy requires more than checking turnover and reading the latest annual accounts.

A proper pharmacy due diligence process should test the quality and sustainability of NHS income, gross profit, stock, staffing costs, working capital, tax history, VAT treatment, property commitments and regulatory position before you commit to the acquisition.

The pharmacy transaction market remains active. Christie & Co reported that it advised on, valued or sold 1,155 pharmacies worth a combined £869 million during 2025, with first-time buyers accounting for 30% of its transactions.

For buyers, however, transaction activity is not evidence that a particular pharmacy represents a good investment. Each acquisition needs to stand up financially on its own.

This guide explains the financial, tax and pharmacy-specific checks to make when buying a pharmacy in the UK in 2026.

Important: NHS contractual arrangements differ across England, Scotland, Wales and Northern Ireland. References in this guide to NHS England’s pharmaceutical list and change-of-ownership process apply specifically to England. Tax principles may also depend on the transaction structure and individual circumstances.

What Should You Check Before Buying a Pharmacy?

Before buying a pharmacy, a buyer should normally investigate at least the following areas:

AreaWhat you need to understand
Financial performanceWhether reported profit is genuine, sustainable and properly supported
NHS incomeWhether income recorded in the accounts reconciles to actual NHS payment records
Gross marginWhat is driving margin and whether current performance is repeatable
StockQuantity, valuation, ageing, obsolete stock and completion arrangements
StaffingPayroll, locum reliance, employment commitments and future staffing requirements
Cash flowWhether the pharmacy can fund suppliers, payroll, tax and borrowing
TaxHistoric compliance and the tax consequences of the proposed purchase structure
VATCurrent VAT treatment and whether the transaction itself qualifies for any special treatment
LiabilitiesLoans, creditors, tax liabilities, accruals, claims and other obligations
NHS arrangementsWhether the proposed ownership structure requires an NHS change-of-ownership process
GPhC requirementsPharmacy premises and ownership notification requirements
PropertyLease terms, rent, repairs, security, assignment and future commitments
Purchase structureWhether you are acquiring shares or selected business assets
FundingWhether maintainable post-acquisition cash flow can support the proposed borrowing

The purpose of due diligence is not simply to find problems.

It is to understand what you are actually buying, what the pharmacy is capable of earning after completion and whether the price and financing assumptions remain reasonable once the underlying figures have been tested.

Start by Defining Exactly What You Are Buying

One of the first questions should be:

Are you buying the shares in an existing company, or are you buying the pharmacy business and its assets?

The distinction matters.

In a share purchase, the company itself generally remains in existence and you acquire ownership of that company. That can mean historic liabilities and obligations remain within the company after the transaction.

In an asset purchase, the buyer acquires specified assets and business components under the transaction agreement. Exactly what transfers needs to be established clearly.

That might include:

  • stock;
  • fixtures and equipment;
  • goodwill;
  • trading names;
  • telephone numbers;
  • digital assets;
  • contracts;
  • leasehold interests;
  • and other operational assets.

The transaction structure can affect tax, VAT, NHS processes, liabilities, financing and the documentation required.

It should therefore be considered before the purchase price is viewed as final.

If you are considering pharmacy ownership more generally rather than specifically acquiring an existing pharmacy, Kudos Accounting’s guide to starting a pharmacy business in the UK covers the wider financial setup considerations.

Review at Least Several Years of Financial Performance

One year’s accounts rarely tell you enough about a pharmacy.

Ideally, due diligence should look across several periods so you can see trends rather than relying on one unusually strong or weak year.

The information reviewed can include:

  • statutory accounts;
  • detailed profit and loss reports;
  • current management accounts;
  • balance sheets;
  • corporation tax returns where applicable;
  • VAT returns;
  • payroll information;
  • NHS payment information;
  • supplier statements;
  • bank information;
  • stock records;
  • and forecasts.

The objective is to reconcile the story being presented by the seller with the financial evidence.

Do not focus on turnover alone

A pharmacy with rising turnover is not automatically becoming more profitable.

Revenue can rise while gross margin falls.

Prescription activity can increase while payroll, locum and supplier costs increase faster.

Clinical-service activity can grow without making a meaningful contribution to profit if the additional staffing and operating costs are not understood.

The more useful question is:

What level of maintainable profit and cash flow can this pharmacy reasonably generate after acquisition?

That requires looking below revenue.

Verify the Pharmacy’s NHS Income

For many community pharmacies, NHS-related income is fundamental to business value.

A buyer should therefore avoid accepting a single income figure from the profit and loss account without understanding what sits behind it.

Depending on the pharmacy, income may include:

  • dispensing-related NHS income;
  • clinical service income;
  • Pharmacy First;
  • New Medicine Service activity;
  • vaccination services;
  • contraception services;
  • independent prescribing income as services develop;
  • locally commissioned services;
  • private services;
  • and OTC or retail income.

The accounting system should allow these different revenue streams to be understood and, where appropriate, reconciled.

For pharmacies in England, the 2026/27 Community Pharmacy Contractual Framework provides total CPCF funding of £3.636 billion, increases the Single Activity Fee to £1.52 and increases retained medicine margin to £1.1 billion. Independent prescribing is also being introduced into the national framework from autumn 2026. These are sector-wide arrangements, not guaranteed income or profit for an individual pharmacy.

Kudos Accounting’s detailed 2026/27 Community Pharmacy CPCF guide explains the current funding framework in greater detail.

For acquisition due diligence, the more important task is testing what the individual pharmacy has historically earned and why.

Check Whether NHS Income Reconciles Properly

A buyer should look for a clear audit trail between pharmacy activity, NHS payment documentation, accounting records and cash received.

Differences do not automatically mean something is wrong.

Timing differences, adjustments and the structure of NHS pharmacy payments can create reconciliation issues.

But unexplained differences deserve investigation.

Questions to consider include:

Can reported NHS revenue be traced to supporting records?

Are material differences between payment periods explained?

Have income streams been posted consistently?

Are service payments separated clearly enough to understand performance?

Are there old reconciliation differences sitting on the balance sheet?

A pharmacy can have strong headline turnover while weak reconciliation processes hide errors in management information.

For a buyer, the reliability of the underlying records matters almost as much as the final number.

Analyse Gross Profit and Medicine Purchasing

Gross profit deserves particular attention during pharmacy financial due diligence.

The buyer needs to understand what has driven historical margin and whether that performance is likely to continue.

Changes can arise because of:

  • medicine purchase prices;
  • reimbursement;
  • dispensing mix;
  • buying groups;
  • supplier terms;
  • rebates and credits;
  • category movements;
  • retail mix;
  • stock adjustments;
  • and accounting treatment.

Do not assume that one strong historic gross margin will repeat after the acquisition.

Supplier arrangements may change when ownership changes.

Previous buying terms may not be available to the buyer.

Historic rebates may include one-off arrangements.

The new owner may also operate the pharmacy differently.

A sensible acquisition model therefore separates historical results from the assumptions used to forecast future performance.

Kudos Accounting’s pharmacy stock accounting and gross profit guide explains the relationship between inventory, purchasing, margin and cash flow in more detail.

Do Not Treat Stock as a Minor Completion Adjustment

Stock can represent a significant amount of working capital.

The acquisition agreement should make clear how stock will be counted and valued at completion.

A buyer should understand:

  • the basis of valuation;
  • historical stock levels;
  • high-value medicines;
  • slow-moving stock;
  • obsolete items;
  • expired products;
  • retail inventory;
  • stock held for specific patients;
  • stock ordering patterns;
  • supplier credits;
  • and any unusual build-up before completion.

A large stock figure is not necessarily a positive sign.

It may reflect deliberate purchasing ahead of expected shortages or favourable supplier terms.

But it could also reflect over-ordering, slow-moving inventory or weak controls.

If £50,000 of stock is included in the purchase price, you need confidence that the stock has genuine economic value.

Normalise Payroll and Locum Costs

People are one of the largest costs in most community pharmacies.

Review the pharmacy’s existing team and distinguish between:

  • employed pharmacists;
  • dispensers;
  • pharmacy technicians;
  • counter staff;
  • administrative staff;
  • delivery staff;
  • locum pharmacists;
  • owners or directors working in the business;
  • and family members where relevant.

Historic accounts can sometimes understate the future cost of operating the pharmacy.

For example, the existing owner may work significant hours while taking remuneration in a way that does not reflect the cost of employing a replacement pharmacist or manager.

If the seller leaves after completion, ask:

What will it cost me to replace the work currently performed by the owner?

This adjustment can materially change maintainable profit.

Likewise, high locum expenditure deserves investigation rather than automatic criticism.

It might indicate:

  • recruitment problems;
  • maternity or sickness cover;
  • owner absence;
  • growth;
  • temporary staffing needs;
  • or an underlying difficulty retaining permanent pharmacists.

The reason determines whether the cost is likely to continue.

Look Beyond Profit and Test Cash Flow

Profit does not repay the bank.

Cash does.

That distinction is particularly important when buying a pharmacy using acquisition finance.

Your financial model should consider the timing of:

  • NHS receipts;
  • card and retail receipts;
  • supplier payments;
  • payroll;
  • PAYE and National Insurance;
  • VAT;
  • Corporation Tax or other business taxes;
  • rent;
  • loan repayments;
  • equipment finance;
  • stock purchases;
  • drawings or dividends;
  • and capital expenditure.

A pharmacy can appear profitable while experiencing severe cash pressure because the timing of cash inflows and outflows is misaligned.

Build a post-acquisition cash-flow model

Before completion, model the business under more than one scenario.

For example:

ScenarioQuestions to test
Base caseWhat happens if performance continues broadly as expected?
Margin pressureCan the pharmacy service its debt if gross margin weakens?
Staffing pressureWhat if additional pharmacist or locum cover is required?
Revenue pressureWhat happens if dispensing or service income falls?
Working-capital pressureWhat happens if supplier terms become less favourable?
Growth caseHow much additional working capital is required if activity rises?

A lender may approve a transaction.

That does not necessarily mean the pharmacy will generate the level of free cash flow you personally expect.

The acquisition needs to work under realistic operating assumptions.

Review Management Accounts, Not Just Annual Accounts

Annual accounts are important, but acquisition decisions often need more recent information.

If the last statutory accounts are nine months old, the pharmacy could already be trading differently.

Ask for up-to-date management information.

Useful pharmacy management accounts can help analyse:

  • NHS income;
  • clinical service income;
  • gross profit;
  • gross margin;
  • payroll;
  • locum expenditure;
  • stock;
  • VAT;
  • cash flow;
  • and budget-versus-actual performance.

Kudos Accounting’s guide to pharmacy management accounts and financial KPIs explains how these measures can be used to assess current financial performance.

During due diligence, consistency is important.

If monthly figures change significantly, ask why.

A falling margin might have a reasonable explanation.

A sudden payroll increase might be temporary.

A sharp rise in NHS income might reflect timing.

Due diligence is about finding the explanation and obtaining evidence for it.

Share Purchase or Asset Purchase?

There is no universal answer to whether a pharmacy should be acquired through a share purchase or asset purchase.

The right structure depends on the pharmacy, existing legal entity, liabilities, premises, tax position, regulatory requirements and negotiations between buyer and seller.

A simplified comparison looks like this:

IssueShare purchaseAsset purchase
What is acquired?Ownership of the existing companyAgreed business assets
Historic company liabilitiesGenerally remain inside the acquired companyDepends on what is contractually assumed/transferred
Tax on acquisitionShare-transfer taxes may applyTax treatment depends on assets acquired
GoodwillCompany remains owner of its existing assetsGoodwill may form part of purchase consideration
NHS implicationsDepends on whether the legal contractor changesChange of legal person can trigger change-of-ownership requirements
Due diligence emphasisHistoric company liabilities are especially importantAsset perimeter and transfer arrangements are especially important

This table is deliberately simplified.

The structure should be modelled before binding agreements are signed.

Understand the Tax Position Before You Commit

The tax consequences of a pharmacy acquisition depend heavily on the deal structure.

Stamp Duty on a share purchase

When existing shares in a UK company are purchased, Stamp Duty or Stamp Duty Reserve Tax will usually apply at 0.5% of the consideration, subject to the detailed rules and exemptions.

For paper stock-transfer transactions over £1,000, HMRC states that Stamp Duty is generally 0.5%, rounded up to the nearest £5.

That is only one element of transaction tax.

It should not determine the structure on its own.

VAT and a transfer of a going concern

An asset purchase can also raise important VAT questions.

HMRC’s Transfer of a Business as a Going Concern rules provide that, where the necessary conditions are satisfied, the transfer is treated as neither a supply of goods nor services for VAT purposes and VAT is therefore not charged on the qualifying transfer.

Whether the rules apply depends on the actual transaction.

Do not simply assume that buying an operating pharmacy automatically makes the transaction a TOGC.

Goodwill

Goodwill can represent a significant component of a pharmacy transaction.

The Corporation Tax treatment of purchased goodwill is restricted and depends on detailed conditions. HMRC’s current guidance confirms that relief may be available for qualifying acquisitions involving qualifying intellectual property, while restrictions continue to apply in other circumstances.

The accounting treatment of goodwill and its tax treatment should therefore not be assumed to be the same.

Equipment and capital allowances

Where qualifying plant or machinery is acquired, capital allowances may also be relevant.

HMRC currently allows an Annual Investment Allowance of up to £1 million on qualifying plant and machinery, subject to the relevant conditions.

In a pharmacy transaction, purchase-price allocation can therefore have genuine tax consequences.

HMRC specifically recognises that the price paid for a business may need to be apportioned between underlying assets for matters including capital allowances, land taxes and goodwill treatment.

This is one reason tax advice is more useful before heads of terms and the purchase agreement become fixed than after completion.

Review the Pharmacy’s VAT Position

A pharmacy can have multiple supplies with different VAT treatments.

During due diligence, review:

  • VAT returns;
  • VAT reconciliations;
  • retail accounting;
  • treatment of private services;
  • exempt and taxable income;
  • input VAT recovery;
  • partial exemption calculations where applicable;
  • and correspondence with HMRC.

Kudos Accounting’s pharmacy VAT partial exemption guide explains why the mixture of NHS healthcare, retail and private activities can create additional VAT complexity.

VAT errors matter particularly in a share acquisition because the company continues after the buyer acquires it.

Historic tax exposures do not disappear merely because the shareholders change.

Review the Balance Sheet for Hidden Financial Pressure

A profit and loss account receives most of the attention during a business sale.

The balance sheet can reveal equally important issues.

Review items such as:

  • trade creditors;
  • tax liabilities;
  • PAYE;
  • VAT balances;
  • loans;
  • finance agreements;
  • directors’ loan accounts;
  • accruals;
  • provisions;
  • outstanding supplier credits;
  • debtors;
  • stock;
  • fixed assets;
  • and cash.

Ask for explanations where balances are old, unusual or unsupported.

Check company charges

If you are buying shares in a limited company, Companies House records should also be reviewed.

A registered charge is security granted over a company’s assets for borrowing, such as a mortgage or other secured facility. Companies House records can therefore help identify existing security interests that need to be understood as part of the transaction.

Companies House searches are useful due diligence.

They do not replace legal investigation.

Understand NHS Change-of-Ownership Requirements

This is where buying a community pharmacy differs fundamentally from buying many ordinary retail businesses.

For pharmacies in England, NHS England’s Pharmacy Manual explains that a change-of-ownership application under Regulation 26 is required where the applicant proposes to provide pharmaceutical services from premises already listed for another provider.

NHS England states that these applications should normally be determined within 30 days of receipt unless there is good cause to take longer.

The precise process depends on the transaction.

A share purchase in which the same corporate legal person continues as contractor can create a different position from an asset transaction in which the legal person providing NHS services changes.

The transaction structure should therefore be checked with pharmacy-specific legal advisers rather than assuming the NHS arrangements simply transfer with the keys.

Pay particular attention to debts and liabilities

NHS England’s Pharmacy Manual contains an especially important warning.

Where a retail pharmacy business is purchased on a debts and liabilities basis, the previous contractor code may be retained, meaning electronic prescription nominations do not need to move to a new code.

However, NHS England states that the new owner will also be liable for monies owed to the commissioner by the previous owner.

Its guidance specifically recommends that applicants obtain professional advice before submitting this type of change-of-ownership application.

This is exactly the type of issue that should be identified before completion rather than after it.

Do Not Forget GPhC Requirements

NHS contractual arrangements are not the only regulatory consideration.

The General Pharmaceutical Council has recently reminded pharmacy buyers and sellers that when ownership of registered pharmacy premises changes, the new owner must notify the GPhC within 28 days using the required change-of-ownership process.

Failure to complete the necessary registration steps can have serious operational consequences.

Regulatory planning therefore needs to form part of the completion timetable rather than being treated as an administrative job for later.

Review the Premises Carefully

The pharmacy’s location may be commercially important, but the property obligations attached to it can materially affect the investment.

Where premises are leasehold, review matters including:

  • remaining lease term;
  • rent;
  • rent-review provisions;
  • service charges;
  • repair obligations;
  • assignment requirements;
  • landlord consent;
  • break clauses;
  • permitted use;
  • dilapidation exposure;
  • and future refurbishment commitments.

A profitable pharmacy with an unattractive property obligation can become a very different investment.

The buyer’s solicitor should investigate the legal title and lease position separately from the financial review.

Test Supplier and Buying Arrangements

The pharmacy’s historical gross margin may depend partly on commercial arrangements that will not automatically continue after completion.

Review:

  • main wholesalers;
  • buying-group arrangements;
  • rebate structures;
  • payment terms;
  • credit limits;
  • direct-to-pharmacy arrangements;
  • equipment leases;
  • software contracts;
  • and other significant suppliers.

Then ask:

Will these terms be available to me after completion?

A pharmacy generating an attractive margin under the seller’s supplier arrangements could produce a lower margin if the buyer begins with different purchasing terms.

This should be reflected in the acquisition forecast.

Look for Financial Red Flags

No single red flag necessarily means that you should abandon an acquisition.

It means the issue needs investigation.

Potential red flagQuestion to ask
Turnover rising but profit fallingWhich costs or margins have deteriorated?
Large unexplained stock balanceIs stock genuinely usable and correctly valued?
Falling gross marginIs the cause temporary or structural?
Heavy locum relianceWill this continue after completion?
Seller works substantial unpaid/underpaid hoursWhat is the true replacement staffing cost?
Weak NHS reconciliationsCan reported income be verified independently?
Large old creditorsWhy have they not been paid?
Unusual directors’ loan balanceWhat happens to it on completion?
Missing VAT workingsIs there an unresolved VAT exposure?
Historic tax enquiriesCould liabilities remain in the business?
Poor management informationHow reliable are the earnings used for valuation?
Lease close to expiryIs renewal available and on what terms?
Supplier terms likely to changeWhat happens to future margin and cash flow?
Significant debt or chargesHow will these be discharged or dealt with?
One-off profit adjustmentsAre the seller’s adjusted earnings genuinely maintainable?

Do Not Pay for Profit That Will Disappear After Completion

The most important acquisition calculation is not:

What profit did the pharmacy make last year?

It is:

What sustainable profit will this pharmacy make under my ownership?

Suppose the seller reports an adjusted annual profit of £180,000.

You then identify:

  • £35,000 required for replacement pharmacist cover;
  • £12,000 of buying benefits you cannot replicate;
  • £8,000 of additional software and compliance costs;
  • and £10,000 of maintenance expenditure required each year.

The economic picture is very different.

Likewise, there may be genuine upside that the historical accounts do not capture.

The purpose of financial due diligence is to establish a defensible maintainable-earnings figure before valuation, funding and affordability decisions are finalised.

Build the First-Year Budget Before You Buy

Do not wait until completion to prepare a budget.

Create a first-year financial model before exchanging contracts.

It should incorporate:

  • expected NHS income;
  • clinical services;
  • retail and private income;
  • medicine costs;
  • staff costs;
  • locum requirements;
  • rent;
  • supplier terms;
  • software;
  • insurance;
  • professional fees;
  • debt servicing;
  • tax;
  • VAT;
  • planned capital expenditure;
  • and working-capital requirements.

Then compare actual post-completion performance with that model through monthly management accounts.

That converts due diligence from a one-off transaction exercise into the financial baseline for managing the new pharmacy.

When Should You Involve a Pharmacy Accountant?

Ideally, before the transaction structure and purchase assumptions are fixed.

A specialist accountant can help you:

  • review historical accounts;
  • test adjusted profit;
  • analyse margins;
  • review stock;
  • assess payroll and owner replacement costs;
  • model cash flow;
  • review tax and VAT;
  • compare transaction structures;
  • prepare lender forecasts;
  • assess working-capital requirements;
  • and establish post-acquisition management reporting.

The accountant should work alongside, rather than replace, the pharmacy solicitor, lender, valuation adviser and regulatory specialists.

For buyers who need financial due diligence, tax planning or ongoing accounting support, Kudos Accounting’s specialist pharmacy accountants work with pharmacy businesses on accounting, tax, VAT, payroll, bookkeeping and financial planning.

Final Checklist Before Buying a Pharmacy

Before proceeding, make sure you can answer five fundamental questions confidently:

1. Can I verify the earnings?

The reported profit should be supported by underlying financial and pharmacy-specific records.

2. Will those earnings continue under my ownership?

Adjust for staffing, supplier terms, finance costs and other changes after completion.

3. Do I understand the liabilities?

This is especially important in a share acquisition.

4. Is the regulatory completion route clear?

NHS and GPhC requirements should form part of the transaction timetable.

5. Can the pharmacy generate enough cash after debt, tax and reinvestment?

A profitable acquisition can still become financially uncomfortable if working capital and debt servicing have not been modelled properly.

Buying a pharmacy can be a strong route into ownership or expansion, but the quality of the investment depends on what sits behind the headline price.

Good due diligence gives you the evidence to negotiate properly, structure the transaction intelligently and understand the business you will actually own once the sale completes.

Pharmacy Buyer Questions

Frequently Asked Questions

Practical answers to common financial, tax and due diligence questions when buying an existing pharmacy in the UK.

Due Diligence What due diligence should I do before buying a pharmacy?

Due diligence should normally examine the pharmacy’s financial performance, NHS income, gross margin, stock, payroll, locum costs, VAT, tax history, cash flow, liabilities, supplier arrangements, premises and relevant regulatory requirements. The exact scope will also depend on whether you are acquiring shares or business assets.

Accounts How many years of pharmacy accounts should I review?

Reviewing several accounting periods helps you identify trends in turnover, gross margin, payroll, stock and profitability. Recent management accounts should also be reviewed because statutory accounts may not reflect current trading conditions.

Structure Is it better to buy pharmacy shares or business assets?

Neither structure is automatically better. Share and asset purchases can have different consequences for tax, historic liabilities, contracts, VAT and regulatory arrangements. The proposed structure should therefore be reviewed before binding transaction documents are finalised.

Profit How can I tell whether a pharmacy’s profit is sustainable?

Look beyond the reported profit figure. Review NHS income, gross margin, purchasing terms, payroll, locum expenditure, stock movements and one-off adjustments. You should also account for costs that may change when the existing owner leaves the business.

Stock How should pharmacy stock be checked before completion?

Buyers should understand how stock will be counted and valued at completion and investigate expired, obsolete, slow-moving and unusually high-value items. Stock can represent a substantial amount of working capital, so the valuation basis should be clear.

NHS Income Should NHS income be reconciled before buying a pharmacy?

Yes. Reported NHS income should be supported by appropriate payment information and reconciled to the accounting records. Material or unexplained differences should be investigated before relying on the figures when assessing maintainable earnings.

Tax & VAT What tax and VAT issues should I review before buying a pharmacy?

The review may need to consider the purchase structure, historic corporation tax and VAT compliance, Stamp Duty on shares, the VAT treatment of an asset acquisition, capital allowances, goodwill and any existing tax liabilities. The treatment depends on the facts of the particular transaction.

Cash Flow Why should I prepare a cash-flow forecast before buying?

A pharmacy can report an accounting profit while still experiencing cash pressure. A forecast helps test whether NHS receipts, supplier payments, payroll, tax, stock purchases and finance repayments can be managed comfortably after completion.

Red Flags What financial red flags should I look for when buying a pharmacy?

Warning signs can include declining gross margins, unexplained stock growth, weak NHS reconciliations, heavy locum dependence, old creditors, missing VAT workings, unusual profit adjustments, unresolved tax matters and earnings that depend heavily on work performed by the departing owner.

Accountant When should I involve a pharmacy accountant in an acquisition?

Ideally, before the purchase structure, valuation assumptions and funding model are fixed. Early financial due diligence can help identify issues affecting sustainable earnings, working capital, tax, VAT and the amount you are comfortable paying.

Pharmacy Acquisition Support

Buying a Pharmacy? Understand the Numbers Before You Commit

The asking price is only one part of the decision. Financial due diligence can help you understand sustainable profit, working capital, tax exposure and whether the pharmacy can support your acquisition plan.

Financial Due Diligence Review historical accounts, management information, NHS income, margins, payroll, stock and underlying profitability.
Tax & VAT Review Understand the tax and VAT implications of the proposed acquisition structure before the transaction is finalised.
Cash Flow & Forecasting Test funding, debt repayments, working capital and expected post-acquisition performance under realistic assumptions.
Share it :
Facebook
Twitter
LinkedIn
Email

Leave a Reply

Your email address will not be published. Required fields are marked *

Explore more Blogs: